S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Avoro Capital Advisors/Q2 2021

Avoro Capital Advisors

Period: Q2 2021 Β· Filed: 2021-08-16
View on SEC EDGAR β†—
AUM
$5.75B
Total portfolio value
Positions
46
Reported securities
Top Holding
HZNP
14.7% $842.8M
QoQ Changes
+6 / -7
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-08-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
HZNPHORIZON THERAPEUTICS PLC$842.8M14.66%β€”β€”
14.7%
MRTXMIRATI THERAPEUTICS INC$807.6M14.05%β€”β€”
14.1%
UTHRUNITED THERAPEUTICS CORP$538.2M9.36%$179.41$555.91+209.8%
9.4%
XLRNACCELERON PHARMA INC$376.5M6.55%β€”β€”
6.5%
ARGXARGENX SE$285.0M4.96%$301.07$939.68+212.1%
5.0%
ARNAARENA PHARMACEUTICALS INC$277.9M4.83%β€”β€”
4.8%
ASNDASCENDIS PHARMA$249.9M4.35%$131.55$274.50+108.7%
4.3%
IOVAIOVANCE BIOTHERAPEUTICS INC$236.8M4.12%$26.02$4.31-83.4%
4.1%
SRPTSAREPTA THERAPEUTICS INC$186.6M3.25%$77.74$19.28-75.2%
3.3%
ALNYALNYLAM PHARMACEUTICALS INC$169.5M2.95%$169.52$312.78+84.5%
3.0%
VRTXVERTEX PHARMACEUTICALS INC$159.3M2.77%$201.63$528.04+161.9%
2.8%
MDGLMADRIGAL PHARMACEUTICALS INC$138.8M2.41%$97.41$528.10+442.1%
2.4%
BMRNBIOMARIN PHARMACEUTICAL INC$137.7M2.39%$83.44$58.99-29.3%
2.4%
FOLDAMICUS THERAPEUTICS INC$120.0M2.09%β€”β€”
2.1%
CNSTCONSTELLATION PHARMACEUTICALS INC$108.5M1.89%β€”β€”
1.9%
MRSNMERSANA THERAPEUTICS INC$92.3M1.61%β€”β€”
1.6%
KURAKURA ONCOLOGY INC$86.3M1.50%$20.85$11.10-46.8%
1.5%
XENEXENON PHARMACEUTICALS INC$68.0M1.18%$18.62$60.96+227.4%
1.2%
APLSAPELLIS PHARMACEUTICALS INC$63.5M1.11%$63.20β€”
1.1%
PMVPPMV PHARMACEUTICALS INC$62.3M1.08%$34.16$1.22-96.4%
1.1%
GLUEMONTE ROSA THERAPEUTICS INC$62.1M1.08%$22.70$24.21+6.7%
1.1%
ACADACADIA PHARMACEUTICALS INC$59.5M1.04%$24.39$25.97+6.5%
1.0%
MRNSMARINUS PHARMACEUTICALS INC$58.0M1.01%β€”β€”
1.0%
TRILLIUM THERAPEUTICS INC$55.3M0.96%β€”β€”
1.0%
SNDXSYNDAX PHARMACEUTICALS INC$51.5M0.90%$17.17$21.82+27.1%
0.9%
MNKDMANNKIND CORP$47.0M0.82%$5.45$4.52-17.1%
0.8%
CBAYCYMABAY THERAPEUTICS INC$44.9M0.78%β€”β€”
0.8%
ISEEIVERIC BIO INC$40.5M0.71%β€”β€”
0.7%
DCPHDECIPHERA PHARMACEUTICALS INC$39.1M0.68%β€”β€”
0.7%
RLMDRELMADA THERAPEUTICS INC$29.9M0.52%$32.01$6.28-80.4%
0.5%

Quarter-on-Quarter Activity

Q2 2021 vs. Q1 2021

New Positions (6)

TickerIssuerNotionalSince Filing
ASNDASCENDIS PHARMA$249.9M+108.7%
ALNYCALLALNYLAM PHARMACEUTICALS INC$169.5M+84.5%
GLUEMONTE ROSA THERAPEUTICS INC$62.1M+6.7%
CNTACENTESSA PHARMACEUTICALS PLC$11.1M
ARPOAERPIO PHARMACEUTICALS INC$7.6M
ALNYCALLALNYLAM PHARMACEUTICALS INC$1.4M+84.5%

Exited Positions (7)

TickerIssuerNotional
ASCENDIS PHARMA$244.9M
TVTXTRAVERE THERAPEUTICS INC$31.2M
RLAYRELAY THERAPEUTICS INC$17.3M
BDTXBLACK DIAMOND THERAPEUTICS INC$10.7M
RACATHERAPEUTICS ACQUISITION CORP$10.5M
JNCEJOUNCE THERAPEUTICS INC$5.7M
LKFTGALAPAGOS NV$0.2M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
SNDXSYNDAX PHARMACEUTICALS INC$-4.4M+20.0%+27.1%
DCPHDECIPHERA PHARMACEUTICALS INC$-0.9M+19.6%
MNKDMANNKIND CORP$17.6M+15.1%-17.1%
IOVAIOVANCE BIOTHERAPEUTICS INC$-16.5M+13.8%-83.4%
SRPTSAREPTA THERAPEUTICS INC$26.3M+11.6%-75.2%
CNSTCONSTELLATION PHARMACEUTICALS INC$39.5M+8.8%
MRTXMIRATI THERAPEUTICS INC$6.8M+7.0%
KURAKURA ONCOLOGY INC$-26.8M+3.5%-46.8%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
APLSCALLAPELLIS PHARMACEUTICALS INC$-39.5M-76.0%
VRTXVERTEX PHARMACEUTICALS INC$-141.6M-43.6%+161.9%
ADAPYADAPTIMMUNE THERAPEUTICS PLC$-10.2M-43.0%
RLMDRELMADA THERAPEUTICS INC$-23.8M-38.7%-80.4%
PMVPPMV PHARMACEUTICALS INC$-15.3M-22.7%-96.4%
ADVMADVERUM BIOTECHNOLOGIES INC$-54.6M-13.1%
ISEEIVERIC BIO INC$-4.3M-11.4%
ACADACADIA PHARMACEUTICALS INC$-5.0M-2.3%+6.5%
← Back to Hedge Funds